22 . 03 .2023
Press release
Galderma launches FACE by Galderma™, a cutting-edge aesthetic visualization tool that simulates injectable treatment results in real-time
18 . 03 .2023
Press release
AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis
17 . 03 .2023
News story
AAD 2023: Extensive updates from Galderma’s broad and innovative portfolio through posters and presentation sessions
15 . 03 .2023
Press release
Cetaphil Celebrates Global Initiative Highlighting Sensitive Skin with a Month of Skin Science Education
13 . 03 .2023
Press release
Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
02 . 03 .2023
Press release
Cetaphil® unveils digital AI skin analysis tool to empower and educate users with sensitive skin
16 . 02 .2023
Press release
Cetaphil raises awareness of the connection between clothing and sensitive skin
06 . 02 .2023
Press release
Galderma Launches Cutting-Edge Formulation With Alastin Skincare® Resurface Skin Polish Developed To Uncover Visibly Glowing Skin
26 . 01 .2023
Press release
Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
23 . 01 .2023
Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth